Double Thrombolysis with rt-PA in a Patient with Massive Pulmonary Embolism and Antiphospholipid Syndrome
نویسنده
چکیده
T he antiphospholipid syndrome is an autoimmune disease, characterized by the presence of antiphospholipid antibodies, thromboses, repeat spontaneous abortions and thrombocytopenia. The syndrome may be encountered in patients without any clinical or laboratory indications of other systemic disease (primary), or may be encountered within the context of other systemic disease – more often with Systemic Lupus Erythematosus (secondary). The most common clinical manifestations are venous thromboses of the lower limbs, of pulmonary arteries as well as of other vessels (cerebral, renal, etc.) and repeat spontaneous abortions. The treatment of the antiphospholipid syndrome, depends on the location of the thrombosis and the severity of symptoms. We describe a case of a patient with antiphospholipid syndrome with positive antibodies against cardiolipin and lupus anticoagulant, massive pulmonary embolism, deep venous thrombosis of the left lower limb and aggravated personal history (diabetes mellitus, hypothyroidism due to thyroidectomy, hypertension) who underwent thrombolysis treatment (with rt-PA) twice, due to insufficient clinical and laboratory improvement, following the first thrombolysis session.
منابع مشابه
Prognostic Impact of Thrombolysis in Myocardial Infarction Risk Index on Hospitalization Mortality of Patient with Acute Pulmonary Embolism
Introduction: Acute pulmonary embolism (PE) is one of the deadly cardiovascular diseases. One of the indexes proposed in these patients for risk stratification is the Thrombolysis in Myocardial Infarction (TIMI) risk index (TRI), which includes three parameters of systolic blood pressure, age, and heart rate. This study aimed to evaluate the predictive value of TRI on in-hospit...
متن کاملA randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism.
Experiments in animals have demonstrated that recombinant tissue plasminogen activator (rt-PA) produces continuing thrombolysis after it is cleared from the circulation and that thrombolysis is both increased and accelerated, and bleeding is reduced when rt-PA is administered over a short period. In previous studies in patients with thrombotic disease, rt-PA has been shown to be an effective th...
متن کاملAntiphospholipid Syndrome Presenting as Massive Pulmonary Embolism in a Patient with Sarcoidosis
Sarcoidosis is a systemic, chronic disease of unknown etiology that is characterized by non-caseating granulomas in any tissue. Impairment of cellular immunity is known to play a major role in this disease. Humoral abnormalities such as the occasional presence of anti double-stranded DNA (antids DNA), antinuclear antibody (ANA) and rheumatoid factor (RF) have also been observed in patients with...
متن کاملTreatment of canine embolic pulmonary hypertension with recombinant tissue plasminogen activator. Efficacy of dosing regimes.
We investigated effects of two dosing regimes of recombinant tissue plasminogen activator (rt-PA) and sodium heparin on pulmonary thrombolysis in a canine model of pulmonary hypertension, induced by injection of radioactive blood clots. By continuously counting over both lung fields with a mobile gamma camera, we correlated rate and extent of pulmonary thrombolysis with corresponding pulmonary ...
متن کاملAcute Superior Mesenteric Vein Thrombosis in a Patient with Primary Antiphospholipid Syndrome: A Case Report and Brief Review of the Literature
Acute superior mesenteric vein thrombosis is an uncommon but life threatening disease condition. In the setting of antiphospholipid syndrome, it is rare. This is a case of a 49 year old male who presented with a 2 day history of nausea, vomiting and abdominal pain. He had a previous history of deep vein thrombosis and pulmonary embolism about a year ago. Triple phase computed tomography confirm...
متن کامل